Phase 3 trial evaluating the immunogenicity and safety of a three-dose BioThrax® regimen for post-exposure prophylaxis in healthy adults - Hopkins, Robert J.; Howard, Cris; Hunter-Stitt, Ericka; Kaptur, Paulina E.; Pleune, Brett; Muse, Derek; Sheldon, Eric; Davis, Matthew; Strout, Cynthia; Vert-Wong, Katya (Vaccine, 2014)
Keywords: Adolescent; Adult; adults; Aged; Allergy and Immunology; Anthrax; Anthrax - prevention & control; Anthrax Vaccines - administration & dosage; Anthrax Vaccines - adverse effects; Anthrax Vaccines - immunology; Anthrax Vaccines - therapeutic use; anti-infective agents; Antibiotics; antibodies; Antibodies, Bacterial - blood; Antibodies, Neutralizing - blood; Antimicrobial agents; Applied microbiology; Bacteriology; Biological and medical sciences; BioThrax; Clinical trial; confidence interval; Diaries; disease control; Female; Fundamental and applied biological sciences. Psychology; Healthy Volunteers; Humans; immune response; Immunization, Secondary; Immunogenicity; injection site; Male; Microbiology; Middle Aged; Miscellaneous; Neutralization; pain; Post-Exposure Prophylaxis; Prophylaxis; rabbits; Safety; Toxins; Vaccine; Vaccines; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects); Young Adult; Clinical trial; Post-exposure prophylaxis; Vaccine; BioThrax; Immunogenicity; Anthrax; Bacillus anthracis; Bacillaceae; Infection; Prevention; Bacillales; Bacteriosis; Bacteria; BioThrax(®)